1. Home
  2. QNCX vs WBX Comparison

QNCX vs WBX Comparison

Compare QNCX & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • WBX
  • Stock Information
  • Founded
  • QNCX 2012
  • WBX 2015
  • Country
  • QNCX United States
  • WBX Spain
  • Employees
  • QNCX N/A
  • WBX N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • WBX Industrial Specialties
  • Sector
  • QNCX Health Care
  • WBX Consumer Discretionary
  • Exchange
  • QNCX Nasdaq
  • WBX Nasdaq
  • Market Cap
  • QNCX 100.4M
  • WBX 118.0M
  • IPO Year
  • QNCX 2019
  • WBX N/A
  • Fundamental
  • Price
  • QNCX $1.98
  • WBX N/A
  • Analyst Decision
  • QNCX Strong Buy
  • WBX Buy
  • Analyst Count
  • QNCX 6
  • WBX 4
  • Target Price
  • QNCX $8.00
  • WBX $10.50
  • AVG Volume (30 Days)
  • QNCX 431.7K
  • WBX 44.7K
  • Earning Date
  • QNCX 11-12-2025
  • WBX 11-05-2025
  • Dividend Yield
  • QNCX N/A
  • WBX N/A
  • EPS Growth
  • QNCX N/A
  • WBX N/A
  • EPS
  • QNCX N/A
  • WBX N/A
  • Revenue
  • QNCX N/A
  • WBX $173,788,608.00
  • Revenue This Year
  • QNCX N/A
  • WBX N/A
  • Revenue Next Year
  • QNCX N/A
  • WBX $46.25
  • P/E Ratio
  • QNCX N/A
  • WBX N/A
  • Revenue Growth
  • QNCX N/A
  • WBX N/A
  • 52 Week Low
  • QNCX $0.71
  • WBX $3.69
  • 52 Week High
  • QNCX $2.45
  • WBX $23.19
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 62.46
  • WBX 75.21
  • Support Level
  • QNCX $1.82
  • WBX $6.00
  • Resistance Level
  • QNCX $2.01
  • WBX $7.83
  • Average True Range (ATR)
  • QNCX 0.16
  • WBX 0.60
  • MACD
  • QNCX 0.03
  • WBX 0.21
  • Stochastic Oscillator
  • QNCX 64.48
  • WBX 76.74

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

Share on Social Networks: